Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02033707Phase 1Completed
Phase 1, randomised, double-blind trial (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Rating of 'Drug Liking' on the End of Day Questionnaire at 8 hours. Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02033707.